74 / 144
74
PERGUNTAS & RESPOSTAS
EMD
- Edema Macular Diabético
diabetes. N Engl J Med. 2008;358(24):2545-59.
10. Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A. Intensive gluco-
se control versus conventional glucose control for type 1 diabetes mellitus. Cochrane
Database Syst Rev. 2014(2):CD009122.
11. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association
of glycaemia with macrovascular and microvascular complications of type 2 diabetes
(UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12.
12. Diabetes C, Complications Trial Research G, Nathan DM, Genuth S, Lachin J, Cleary
P, et al. The effect of intensive treatment of diabetes on the development and progres-
sion of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med.
1993;329(14):977-86.
13. Intensive blood-glucose control with sulphonylureas or insulin compared with conven-
tional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-53.
14. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after
tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008;359(15):1565-76.
15. Do DV, Wang X, Vedula SS, Marrone M, Sleilati G, Hawkins BS, et al. Blood pressure
control for diabetic retinopathy. Cochrane Database Syst Rev. 2015;1:CD006127.
16. Lim LS, Wong TY. Lipids and diabetic retinopathy. Expert opinion on biological therapy.
2012;12(1):93-105.
17. Benarous R, Sasongko MB, Qureshi S, Fenwick E, Dirani M, Wong TY, et al. Differen-
tial association of serum lipids with diabetic retinopathy and diabetic macular edema.
Investigative ophthalmology & visual science. 2011;52(10):7464-9.
18. Sasaki M, Kawasaki R, Noonan JE, Wong TY, Lamoureux E, Wang JJ. Quantitative mea-
surement of hard exudates in patients with diabetes and their associations with serum
lipid levels. Investigative ophthalmology & visual science. 2013;54(8):5544-50.
19. Das R, Kerr R, Chakravarthy U, Hogg RE. Dyslipidemia and Diabetic Macular Edema: A
Systematic Review and Meta-Analysis. Ophthalmology. 2015;122(9):1820-7.
20. Keech AC, Mitchell P, Summanen PA, O’Day J, Davis TM, Mof%tt MS, et al. Effect of
feno%brate on the need for laser treatment for diabetic retinopathy (FIELD study): a
randomised controlled trial. Lancet. 2007;370(9600):1687-97.
21. ChenY, HuY, Lin M, Jenkins AJ, Keech AC, Mott R, et al. Therapeutic effects of PPARalpha
agonists on diabetic retinopathy in type 1 diabetes models. Diabetes. 2013;62(1):261-
72.
22. Bogdanov P, Hernandez C, Corraliza L, Carvalho AR, Simo R. Effect of feno%brate on
retinal neurodegeneration in an experimental model of type 2 diabetes. Acta Diabetol.
2015;52(1):113-22.
23. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular
edema. Curr Diab Rep. 2012;12(4):346-54.
24. Rooney D, Lye WK, Tan G, Lamoureux EL, Ikram MK, Cheng CY, et al. Body mass
index and retinopathy in Asian populations with diabetes mellitus. Acta Diabetol.
2015;52(1):73-80.
25. Theodossiadis PG, Theodoropoulou S, Neamonitou G, Grigoropoulos V, Liarakos V,
Triantou E, et al. Hemodialysis-induced alterations in macular thickness measured
by optical coherence tomography in diabetic patients with end-stage renal disea-
se. Ophthalmologica Journal international d’ophtalmologie International journal of
ophthalmology Zeitschrift fur Augenheilkunde. 2012;227(2):90-4.